Sign in
Taking people in United StatesNo phase

Augmented reality guidance during total knee replacement for knee osteoarthritis

Tests an augmented reality guidance system in knee replacement surgery for osteoarthritis.

Key facts

Who runs it
Foundation for Orthopaedic Research and Education
Where
Tampa, United StatesSee the site
Trial code
Registry title
ARVIS TKA vs Conventional TKA
Status
Recruiting
People taking part
50 people, planned
Started
1 Dec 2024
Expected to end
1 Nov 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Evaluation of Augmented Reality technology in TKA compared to standard TKA
Record updated
9 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with knee osteoarthritis who are scheduled for a first total knee replacement (TKA) with kinematic alignment. It compares augmented reality guidance (ARVIS) with the usual surgery.

Age
Over 18 years old
Sex
All sexes
Disease stage
Osteoarthritis of the affected knee, Killgren Lawrence Grade > III. The other knee must not have more than Grade II.
Earlier treatment
No previous operation on the same knee, such as ACL reconstruction, fracture fixation or an earlier knee replacement.

Main reasons for not taking part

  • Previous surgery on the same knee
  • Osteoarthritis greater than Killgren Lawrence Grade II in the other knee
  • Surgery changed to a different procedure during or shortly after the TKA
  • The TKA was not completed
  • Not able to keep up with study visits or questionnaires, as judged by the investigator

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age over 18 years old
  • Scheduled for primary conventional TKA with kinematic alignment
  • Primary Diagnosis of Osteoarthritis (Killgren Lawrence Grade > III) on affected side
  • Able to provide informed consent

Who cannot take part

  • Patients with a previous operation of the same knee, including ACL reconstruction, fracture fixation, previous arthroplasty
  • Patients that had a conversion to a different procedure intraoperatively or shortly after the TKA
  • Diagnosed with greater than Killgren Lawrence Grade II OA on the contralateral knee
  • Patients that did not complete the TKA
  • Patients the Investigator deems not able to follow through with study requirements such as follow-up visits or PROM's

Where in United States

  • Florida Orthopaedic InstituteTampa, United StatesContact: Debbi Warren, RNTaking people

About the trial

What the trial wants to find out

This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

The 2 groups in the trial

  • ARVIS armTreatment being tested

    TKA using ARVIS software

    Treatment: Evaluation of Augmented Reality technology in TKA compared to standard TKA

  • conventional TKAPlacebo, for comparison

    Conventional Total Knee Arthroplasty

    Treatment: Evaluation of Augmented Reality technology in TKA compared to standard TKA

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Prospective Study Using Augmented Reality Versus Conventional Jig Controls in Total Knee Arthroplasty for Osteoarthritis
Plain-language title
Augmented reality guidance during total knee replacement for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
9 September 2026